Abstract
There exist various kinds of motor disturbance due to central lesions. Spasticity, rigidity, muscular hypotonia and abnormal involuntary movement may obviously produce disturbance of smooth performance of voluntary movement. On the other hand, initiation and continuation of movement can also be disturbed by central lesions. Parkinsonism seems to be a good example presenting many of these features. Akinesia, one of the main motor symptoms, is especially important, but the term »akinesia« in symptomatology of Parkinsonism is not clearly enough defined and is vaguely used (9). From clinical, physiological and pharmacological analysis three different types of akinesia are proposed by the author as will be described below.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barbeau, A. Contribution of levodopa therapy to the neuropharmacology of akinesia. In: Parkinson’s Disease, J. Siegfried (Ed.) Hans Huber (Publ.), Bern, 151–174, 1976.
Inagaki, C., Fujiwara, H., Tanaka, C. Inhibitory effect of (+)threo-3,4-dihydroxyphenylserine (DOPS) on decarboxylation of (-)threo-DOPS. Jap. J. Pharmacol. 26: 380–382, 1976.
Martin, J.P. The basal ganglia and posture, Pitman Medical Publ. Co., London, p. 17, 1967.
Nagatsu, T., Kato, T., Numata, Y., Ikuta, K., Sako, M., Nagatsu, I., Kondo, Y., Inagaki, S., Iizuka, R., Hori, A., Narabayashi, H. Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain. Clin. Chim. Acta 57: 221–232, 1977.
Nagatsu, T., Kato, T., Nagatsu, I., Kondo, Y., Inagaki, S., Jizuka, R., Narabayashi, H. Catecholamine-related enzymes in the brain of patients with Parkinsonism and Wilson’s disease. In: Advances in Neurology, L.J. Poirier, T.L. Sourkes and P.J. Bedard (Eds.) Raven Press,New York, Vol. 24: 283–292, 1979.
Nagatsu, T., Wakui, Y., Kato, T., et al. Dopamine beta-hydroxylase activity in cerebrospinal fluid of parkinsonian patients. Biomed. Res. 3: 95–98, 1982.
Nakamura, R., Nagasaki, H., Narabayashi, H. Arrhythmokinesia in Parkinsonism. In: Advances in Parkinsonism, W. Birkmayer and O. Hornykiewicz (Eds.) Roche, Basle, 258–268, 1976.
Narabayashi, H., Imai, H., Yokochi, M., et al. Cases of pure akinesia without rigidity and tremor and with no effect by L-Dopa therapy. In: Advances in Parkinsonism, W. Birkmayer and O. Hornykiewicz (Eds.) Roche, Basle, 335–342, 1976.
Narabayashi, H. Clinical analysis of akinesia. J. Neural Transmission Suppl. 16: 129–136, 1980.
Narabayashi, H., Kondo, T., Hayashi, A., et al. L-threo-3,4-dihydroxyphenylserine.treatment for akinesia and freezing of Parkinsonism. Proc. Japan Acad. 57 (Ser.B): 351–354, 1981.
Narabayashi, H., Nakamura, R. The freezing phenomenon. Problems in long-term L-Dopa treatment for Parkinsonism. In: Research Progress in Parkinson’s Disease, F.C. Rose and R. Capildeo (Eds.) Pitman Medical, Tunbridge Wells, Kent, 248–253, 1981.
Ohye, C., Tsukahara, N., Narabayashi, H. Rigidity and disturbance of reciprocal innervation. Confin. Neurol. 26: 24–40, 1965.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Narabayashi, H. (1985). Akinesia in Parkinsonism Pharmacological and Physiological Analysis. In: Struppler, A., Weindl, A. (eds) Electromyography and Evoked Potentials. Advances in Applied Neurological Sciences, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70122-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-70122-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70124-5
Online ISBN: 978-3-642-70122-1
eBook Packages: Springer Book Archive